Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

Table 3 Recurrent identical amplicons observed in at least two tumors

Chromosome	Start position^a	End position^a	Candidate genes	Maximum ratio	Number of cases
					MBC	BLC
1q21.2–21.3	148.109	150.70	SNX27, FLG, S100, LRN	2.2	3	0
8p11.21	40.01	42.35	MYST3, ANK1	2.9	3	0
8q24	122.64	128.80	MYC, KIAA0196	2.3	2	2
10p15.3	0.25	1.00	ZMYND11	2.3	3	0
12p13.32–13.33	2.46	4.31	CCND2	2.8	2	0
12p13.2-13.31	5.16	6.37	TNFRSF1A, NTF3, LTBR, CD9	2.7	3	0
12p13.2	7.80	11.7	PRR4, Nanog, CD69, STELLA/DPPA3, PHC1	3.8	3	0
12p13.2	11.95	12.11	ETV6, BCL2L14	9.1	3	0
Xp11.22	51.21	53.95	SSX1, SSX2	2.8	0	2
Xq28	152.66	153.69	MTCP1, TZ, TKTL1, FLNA	2.8	3	1

MBC, medullary breast carcinoma; BLC, basal-like carcinoma. ^aUCSC Genome Browser on Human May 2004 Assembly; positions are given in megabases.

ISSN: 1465-542X